Position in NRIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,512,680
+$1,642,558 QoQ
Shares Held
103,573
+84.5% QoQ
Ownership
0.100%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#80
of 210 holders
Holding Since
Sep 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NRIX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026WELLS FARGO & COMPANY/MN holds $1,567,775,044 across 417 Biotechnology names. NRIX ranks #85 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
749,528 | $372,313,040 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
1,390,428 | $108,828,797 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
310,047 | $93,333,446 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
140,802 | $87,795,677 | |
| 5 | EXEL |
Exelixis, Inc.
|
717,840 | $39,057,673 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
178,780 | $33,481,916 | |
| 7 | ARGX |
Argenx SE
|
34,453 | $31,964,458 | |
| 8 | INCY |
Incyte Corp
|
255,064 | $28,914,053 |
All Filings in NRIX
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,512,680 | 103,573 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $870,122 | 56,137 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $2,235,689 | 117,854 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $560,904 | 60,704 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $593,772 | 52,131 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $508,819 | 42,830 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $740,016 | 39,279 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $916,842 | 40,803 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $529,033 | 25,349 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $311,154 | 21,167 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $197,689 | 19,156 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $267,601 | 34,046 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $399,729 | 40,013 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $296,858 | 33,430 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $18,666 | 1,700 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $34,216 | 2,626 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $37,502 | 2,960 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $150,270 | 10,726 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $606,676 | 20,956 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $436,037 | 14,554 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $8,489 | 320 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $429,507 | 13,815 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $1,562,029 | 47,507 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $1,230,436 | 35,246 | Shares | Defined | 2020-11-05 | |
| No filing history on record for this holder in this stock. | ||||||